American International Group’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,302
| Closed | -$63.7K | – | 3094 |
|
|
2023
Q1 | $63.7K | Buy |
20,302
+405
| +2% | +$1.27K | ﹤0.01% | 2643 |
|
|
2022
Q4 | $117K | Sell |
19,897
-73
| -0.4% | -$431 | ﹤0.01% | 2432 |
|
|
2022
Q3 | $175K | Buy |
19,970
+282
| +1% | +$2.47K | ﹤0.01% | 2235 |
|
|
2022
Q2 | $148K | Buy |
19,688
+507
| +3% | +$3.81K | ﹤0.01% | 2369 |
|
|
2022
Q1 | $465K | Sell |
19,181
-1,351
| -7% | -$32.8K | ﹤0.01% | 1760 |
|
|
2021
Q4 | $661K | Sell |
20,532
-614
| -3% | -$19.8K | ﹤0.01% | 1642 |
|
|
2021
Q3 | $945K | Buy |
21,146
+1,849
| +10% | +$82.6K | 0.01% | 1471 |
|
|
2021
Q2 | $730 | Buy |
19,297
+13,077
| +210% | +$495 | ﹤0.01% | 1697 |
|
|
2021
Q1 | $230 | Buy |
6,220
+16
| +0.3% | +$1 | ﹤0.01% | 2294 |
|
|
2020
Q4 | $206 | Buy |
+6,204
| New | +$206 | ﹤0.01% | 2273 |
|